Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -2.71%28.4014.1%$167.11m
AMRNAmarin Corp. Plc -2.60%20.221.7%$161.85m
AXSMAxsome Therapeutics, Inc. -2.92%85.201.9%$90.60m
BHCBausch Health Cos., Inc. -2.71%28.400.0%$84.60m
GWPHGW Pharmaceuticals Plc -1.20%114.516.2%$73.62m
JAZZJazz Pharmaceuticals Plc -2.25%145.742.3%$63.95m
PRGOPerrigo Co. Plc -1.24%58.746.8%$63.73m
ICPTIntercept Pharmaceuticals, Inc. -3.02%96.6516.9%$61.51m
SAVACassava Sciences, Inc. -7.18%7.180.0%$60.84m
SAGESAGE Therapeutics, Inc. -3.46%68.028.6%$58.61m
HZNPHorizon Therapeutics Plc -2.83%36.066.6%$56.41m
MNKMallinckrodt Plc -7.68%5.1720.9%$43.68m
ICLRICON plc 0.09%174.954.2%$39.55m
CTLTCatalent, Inc. 0.05%61.602.4%$37.97m
UTHRUnited Therapeutics Corp. -1.70%89.3314.3%$34.80m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.